glp-1 agonists drugs Receptor Agonists: The New Wave in Diabetes Management GLP-1: Genetic Variants Related to

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes

Jiang, Y

Risk of orthostatic hypotension associated with sodium-glucose cotransporter-2 inhibitor treatment: a meta-analysis of randomized controlled trials

Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis

Studies have also found that its antioxidant effect can further reduce oxidative stress damage in patients with PCOS by increasing total glutathione and total antioxidant capacity (69)

Nephrologists defined their ideal patient as someone with diabetic kidney disease exhibiting persistently elevated urinary albumin-to-creatinine ratio (ACR) or decline in eGFR with proper reninangiotensinaldosterone system (RAAS) blockade, starting with SGLT2is first and subsequently adding GLP1-RAs